Libreville, Gabon — 05 February 2026 ANMAPS Holds Annual Council Meeting, Emphasizing Strengthened Governance and Strategic Priorities for 2026 The Agence nationale du médicament et des autres produits de santé (ANMAPS), Gabon’s National Medicines and Health Products Agency, convened its Ordinary Board of Directors meeting on Wednesday, 4 February, at its headquarters in Libreville.
The session, presided over by Erick Blaise Ndong Aboghe, President of the Board, focused on governance, institutional operations, and strategic directions for the agency. During the meeting, the Board members and the General Directorate of ANMAPS reviewed and adopted key points, including a review of the previous year’s activities, an evaluation of technical and administrative performance, examination of perspectives and priorities for 2026, and validation of the corresponding budget.
The President of the Board, in his remarks, praised the General Directorate, led by Dr Ange Mibindzou Mouelet, for their efforts in modernizing management, continuously improving processes, and strengthening the quality of services.
The international certification ISO 9001 version 2015 was highlighted as a significant advancement and a guarantee of credibility, performance, and transparency in the service of public health. Aboghe also commended the commitment of the Board members and the entire staff, emphasizing the strategic role of ANMAPS in protecting public health.
The Board reaffirmed its support for the General Directorate in implementing the prioritized actions for 2026. Strategic Priorities and Performance Recognition.
The focus of the meeting on strategic planning and performance recognition reflects ANMAPS’commitment to enhancing its services and contributing to the health and safety of the Gabonese population.
The agency’s efforts in modernization and process improvement have been recognized both domestically and internationally, with the ISO certification serving as a testament to its commitment to quality. Looking Ahead.
As the Board looks forward to 2026, it aims to build on the progress made in recent years.
The prioritized actions for the year are expected to guide the agency’s work in areas such as regulatory oversight, public health, and pharmaceutical services. Conclusion.
The Ordinary Board of Directors meeting of ANMAPS marks a significant step in the agency’s journey towards achieving its strategic goals.
The emphasis on governance, performance, and future planning underlines the agency’s dedication to providing effective and high-quality health services in Gabon.
